Director's Interest in Shares

RNS Number : 2698Y

Oxford Biomedica PLC

01 September 2009

 



For immediate release

1 September 2009

Oxford BioMedica plc ('the Company')

Director's Interest in Shares 

Oxford BioMedica (OXB:L) today announced that it has allotted 1,500,000 new Ordinary Shares of 1p each to John Dawson, Chief Executive Officer. The shares are fully paid, and are a one-off share-based bonus payment to John Dawson, in accordance with his contract of employment, for successful achievement of key objectives. The award has been approved by the Company's remuneration committee. The value of the shares at the closing mid-market price on 28 August 2009 (the trading day immediately prior to issue), is £172,500. Following this allotment of shares, John Dawson's interest in Oxford BioMedica shares is 1,500,000 representing 0.28% of the issued share capital. He also has awards under the Company's Long Term Incentive Plan over 5 million Oxford BioMedica shares (0.92% of issued shares). 

By agreeing to this share-based award, John and the remuneration committee have reduced the Company's cash outlay, while demonstrating commitment to the long-term success of the Company.

The new shares rank pari passu in all respects with Oxford BioMedica's existing Ordinary Shares. Application will today be made to the UK Listing Authority and to the London Stock Exchange for the new shares to be admitted to the Official List. Admission is expected to become effective and dealings in the new shares are expected to commence on 04 September 2009. 

Andrew Wood

Company Secretary

1 September 2009

For further information, please contact:
Oxford BioMedica plc:  John Dawson, Chief Executive Officer Andrew Wood, Chief Financial Officer	Tel: [phone]
JPMorgan Cazenove Limited: James Mitford / Gina Gibson	Tel: [phone]
City/Financial Enquiries: Lisa Baderoon / Mary-Jane Elliott / Mark Court Buchanan Communications	Tel: [phone]

 

END

 

 

RDSEANPFDFXNEFE